首页 > 最新文献

Acta Pharmaceutica最新文献

英文 中文
Total phenolic content, flavonoid content and antioxidant potential of Petasites hybridus and related species from Croatia and considerations regarding their pharmaceutical significance. 克罗地亚杂交矮牵牛及相关物种的总酚含量、类黄酮含量和抗氧化潜力,以及对其制药意义的考虑。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0032
Maja Friščić, Katarina Vilić, Sandra Jurić, Kroata Hazler Pilepić, Željan Maleš

Extracts obtained from common butterbur (Petasites hybridus), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). In this study, the total phenolic content, flavonoid content, and antioxidant potential of ten samples of Croatian Petasites species (four P. hybridus, four P. albus, one P. kabli kianus, and one P. paradoxus) obtained by ultrasound-assisted extraction of leaves were compared. The total phenolic content (Folin-Ciocalteu assay) of methanolic leaf extracts ranged from 4.43 ± 0.09 to 10.76 ± 0.60 mg gallic acid equivalent g-1 dry mass (mg GAE g-1 DM) for P. hybridus and from 6.66 ± 0.43 to 19.92 ± 2.90 mg GAE g-1 DM for P. albus samples, while those of P. kablikianus and P. paradoxus were equal to 7.56 ± 0.17 mg GAE g-1 DM and 10.22 ± 0.46 mg GAE g-1 DM, respectively. Flavonoid content (AlCl3 assay) varied between 2.51 ± 0.10 and 4.03 ± 0.08 mg quercetin equivalent g-1 dry mass (mg QE g-1 DM) for P. hybridus and between 2.21 ± 0.09 and 5.22 ± 0.02 mg QE g-1 DM for P. albus samples, while those of P. kablikianus and P. paradoxus were equal to 5.59 ± 0.05 mg QE g-1 DM and 5.50 ± 0.09 mg QE g-1 DM, respectively. Antioxidant potential was in high correlation with total phenolic content (r = 0.93, p < 0.001). Due to the expected contribution of plant polyphenols and flavonoids to the activity of butterbur extracts and their observed great variabilities, determining the content of these compounds may be of interest to the pharmaceutical industry.

从普通毛茛(Petasites hybridus)中提取的提取物(标准化为 petasins)是治疗和/或预防过敏性鼻炎(叶片)和偏头痛(根茎)的现有药物选择。本研究比较了通过超声辅助萃取叶片获得的十种克罗地亚矮牵牛样本(四种杂交矮牵牛、四种白矮牵牛、一种卡布利矮牵牛和一种矛盾矮牵牛)的总酚含量、类黄酮含量和抗氧化潜力。杂交种 P. 的甲醇叶提取物总酚含量(Folin-Ciocalteu 法)为 4.43 ± 0.09 至 10.76 ± 0.60 mg 没食子酸当量 g-1 干重(mg GAE g-1 DM),P. 的甲醇叶提取物总酚含量(Folin-Ciocalteu 法)为 6.66 ± 0.43 至 19.92 ± 2.90 mg GAE g-1 DM,而 P. kablikianus 和 P. paradoxus 的含量分别为 7.56 ± 0.17 mg GAE g-1 DM 和 10.22 ± 0.46 mg GAE g-1 DM。黄酮类化合物含量(AlCl3 检测法)的变化范围为:杂交种 P. 样品介于 2.51 ± 0.10 和 4.03 ± 0.08 毫克槲皮素当量 g-1 干重(mg QE g-1 DM)之间,白头翁 P. 样品介于 2.21 ± 0.09 和 5.22 ± 0.02 毫克 QE g-1 DM 之间,而卡布力翁 P. 样品和矛盾翁 P. 样品的黄酮类化合物含量分别为 5.59 ± 0.05 毫克 QE g-1 DM 和 5.50 ± 0.09 毫克 QE g-1 DM。抗氧化潜力与总酚含量高度相关(r = 0.93,p < 0.001)。由于植物多酚和类黄酮对毛茛提取物活性的预期贡献及其观察到的巨大差异,确定这些化合物的含量可能对制药业有意义。
{"title":"Total phenolic content, flavonoid content and antioxidant potential of <i>Petasites hybridus</i> and related species from Croatia and considerations regarding their pharmaceutical significance.","authors":"Maja Friščić, Katarina Vilić, Sandra Jurić, Kroata Hazler Pilepić, Željan Maleš","doi":"10.2478/acph-2024-0032","DOIUrl":"10.2478/acph-2024-0032","url":null,"abstract":"<p><p>Extracts obtained from common butterbur (<i>Petasites hybridus</i>), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). In this study, the total phenolic content, flavonoid content, and antioxidant potential of ten samples of Croatian <i>Petasites</i> species (four <i>P. hybridus</i>, four <i>P. albus</i>, one <i>P. kabli kianus</i>, and one <i>P. paradoxus</i>) obtained by ultrasound-assisted extraction of leaves were compared. The total phenolic content (Folin-Ciocalteu assay) of methanolic leaf extracts ranged from 4.43 ± 0.09 to 10.76 ± 0.60 mg gallic acid equivalent g<sup>-1</sup> dry mass (mg GAE g<sup>-1</sup> DM) for <i>P. hybridus</i> and from 6.66 ± 0.43 to 19.92 ± 2.90 mg GAE g<sup>-1</sup> DM for <i>P. albus</i> samples, while those of <i>P. kablikianus</i> and <i>P. paradoxus</i> were equal to 7.56 ± 0.17 mg GAE g<sup>-1</sup> DM and 10.22 ± 0.46 mg GAE g<sup>-1</sup> DM, respectively. Flavonoid content (AlCl<sub>3</sub> assay) varied between 2.51 ± 0.10 and 4.03 ± 0.08 mg quercetin equivalent g<sup>-1</sup> dry mass (mg QE g<sup>-1</sup> DM) for <i>P. hybridus</i> and between 2.21 ± 0.09 and 5.22 ± 0.02 mg QE g<sup>-1</sup> DM for <i>P. albus</i> samples, while those of <i>P. kablikianus</i> and <i>P. paradoxus</i> were equal to 5.59 ± 0.05 mg QE g<sup>-1</sup> DM and 5.50 ± 0.09 mg QE g<sup>-1</sup> DM, respectively. Antioxidant potential was in high correlation with total phenolic content (<i>r</i> = 0.93, <i>p</i> < 0.001). Due to the expected contribution of plant polyphenols and flavonoids to the activity of butterbur extracts and their observed great variabilities, determining the content of these compounds may be of interest to the pharmaceutical industry.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"709-723"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in electron paramagnetic resonance (EPR) spectroscopy: A comprehensive tool for pharmaceutical research. 电子顺磁共振(EPR)光谱研究进展:药物研究的综合工具。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0037
Erim Bešić, Zrinka Rajić, Davor Šakić

Electron paramagnetic resonance (EPR) spectroscopy has long been established across various scientific disciplines for characterizing organic radicals, organometallic complexes, protein structures and dynamics, polymerization processes, and radical degradation phenomena. Despite its extensive utility in these areas, EPR spectroscopy's application within pharmaceutical science has historically been constrained, primarily due to factors such as high equipment costs, a steep learning curve, complex spectral deconvolution and analysis, and a traditional lack of emphasis on single-electron chemistry in pharmaceutical research. This review aims to provide a thorough examination of EPR spectroscopy's applications in analyzing a wide array of para-magnetic species relevant to pharmaceutical research. We detail how EPR spectroscopy can be employed to assess free radical scavenging properties in pharmaceutical compounds, elucidate drug mechanisms of action, and explore pharmacokinetics. Additionally, we investigate the role of free radicals in drug-induced toxicity and drug-membrane interactions, while also covering the application of EPR spectroscopy in drug delivery research, advanced studies of metallodrugs, and monitoring of oxygen levels in biological systems through EPR oximetry. The recent advancements in the miniaturization of EPR spectro meters have paved the way for their application in on-site and in-line mo nitoring during the manufacturing process and quality control of pharmaceutical substances and final drug formulations due to being the only direct and non-invasive detection technique for radical detection. Through these discussions, we highlight the substantial contributions of EPR spectroscopy to the advancement of pharmaceutical sciences.

电子顺磁共振(EPR)光谱学早已在各个科学学科中建立,用于表征有机自由基、有机金属配合物、蛋白质结构和动力学、聚合过程和自由基降解现象。尽管EPR光谱在这些领域得到了广泛的应用,但它在制药科学中的应用一直受到限制,这主要是由于设备成本高、学习曲线陡峭、光谱反卷积和分析复杂以及传统上缺乏对药物研究中单电子化学的重视等因素。本文综述了EPR光谱在分析与药物研究相关的一系列对磁物质方面的应用。我们详细介绍了EPR光谱如何用于评估药物化合物中的自由基清除特性,阐明药物作用机制,并探索药代动力学。此外,我们还研究了自由基在药物诱导毒性和药物-膜相互作用中的作用,同时也涵盖了EPR光谱在药物传递研究、金属药物的高级研究以及通过EPR氧饱和度法监测生物系统中氧水平的应用。EPR光谱仪在小型化方面的最新进展为其在制造过程中的现场和在线mo监测以及原料药和最终药物配方的质量控制中应用铺平了道路,因为它是唯一直接和非侵入性的自由基检测技术。通过这些讨论,我们强调了EPR光谱对制药科学进步的重大贡献。
{"title":"Advancements in electron paramagnetic resonance (EPR) spectroscopy: A comprehensive tool for pharmaceutical research.","authors":"Erim Bešić, Zrinka Rajić, Davor Šakić","doi":"10.2478/acph-2024-0037","DOIUrl":"10.2478/acph-2024-0037","url":null,"abstract":"<p><p>Electron paramagnetic resonance (EPR) spectroscopy has long been established across various scientific disciplines for characterizing organic radicals, organometallic complexes, protein structures and dynamics, polymerization processes, and radical degradation phenomena. Despite its extensive utility in these areas, EPR spectroscopy's application within pharmaceutical science has historically been constrained, primarily due to factors such as high equipment costs, a steep learning curve, complex spectral deconvolution and analysis, and a traditional lack of emphasis on single-electron chemistry in pharmaceutical research. This review aims to provide a thorough examination of EPR spectroscopy's applications in analyzing a wide array of para-magnetic species relevant to pharmaceutical research. We detail how EPR spectroscopy can be employed to assess free radical scavenging properties in pharmaceutical compounds, elucidate drug mechanisms of action, and explore pharmacokinetics. Additionally, we investigate the role of free radicals in drug-induced toxicity and drug-membrane interactions, while also covering the application of EPR spectroscopy in drug delivery research, advanced studies of metallodrugs, and monitoring of oxygen levels in biological systems through EPR oximetry. The recent advancements in the miniaturization of EPR spectro meters have paved the way for their application in <i>on-site</i> and <i>in-line</i> mo nitoring during the manufacturing process and quality control of pharmaceutical substances and final drug formulations due to being the only direct and non-invasive detection technique for radical detection. Through these discussions, we highlight the substantial contributions of EPR spectroscopy to the advancement of pharmaceutical sciences.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"551-594"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete blood count parameters and inflammation-related biomarkers in patients with colorectal carcinoma. 结直肠癌患者的全血细胞计数参数和炎症相关生物标记物。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0036
Martha Koržinek, Ivana Ćelap, Marija Fabijanec, Tena Žanić, Neven Ljubičić, Neven Baršić, Donatella Verbanac, Karmela Barišić, Marija Grdić Rajković

The aim of this study was to determine whether there are differences in complete blood count parameters (CBC) and inflammation-related biomarkers, MPV/PC, PLR, NLR, LWR, LMR, NMR, and LCR, among patients with colorectal carcinoma (CRC) and patients with colorectal adenomas. The study included 155 patients who were divided into two groups according to histopathological analysis - 74 adenomas patients and 81 CRC patients. A routine examination of CBC was conducted on Sysmex XN1000 whereas CRP was measured on Alinity ci-series. Statistical analysis was performed by ROC curve analysis using MedCalc Statistical Software. In CRC patients, hemoglobin concentration, hematocrit, MCV, MCH, and MCHC were lower, while RDW was higher (p < 0.001), compared to patients with adenomas. Total leukocyte count (p = 0 .006), absolute neutrophils (p = 0.005), and absolute monocytes (p = 0.007) were lower while relative eosinophils (p = 0.001) and relative basophils (p = 0.001) were higher in CRC patients. Platelet count (p < 0.001) was significantly higher and MPV (p = 0.003) was significantly lower in CRC patients. Furthermore, MPV/PC (p < 0.001) was significantly lower and PLR (p < 0.001) was significantly higher in CRC. Moreover, Receiver Operating Characteristic (ROC) analysis revealed poor diagnostic accuracy, for all tested parameters (AUC was 0.7 or less). PC, MPV, MPV/PC, and PLR were significantly different between study groups, but ROC analysis revealed poor diagnostic accuracy. Lower hemo globin levels in CRC patients are possibly due to more frequent and excessive bleeding. Higher levels of basophils and eosinophils in CRC patients are indicators of inflammatory reaction, which is linked to CRC.

本研究旨在确定结直肠癌(CRC)患者和结直肠腺瘤患者的全血细胞计数参数(CBC)和炎症相关生物标志物 MPV/PC、PLR、NLR、LWR、LMR、NMR 和 LCR 是否存在差异。研究包括 155 名患者,根据组织病理学分析将他们分为两组--74 名腺瘤患者和 81 名 CRC 患者。CBC 的常规检查在 Sysmex XN1000 上进行,而 CRP 则在 Alinity ci-series 上测量。统计分析采用 MedCalc 统计软件进行 ROC 曲线分析。与腺瘤患者相比,CRC 患者的血红蛋白浓度、血细胞比容、MCV、MCH 和 MCHC 较低,而 RDW 较高(p < 0.001)。CRC 患者的白细胞总数(p = 0 .006)、中性粒细胞绝对数(p = 0.005)和单核细胞绝对数(p = 0.007)较低,而嗜酸性粒细胞相对数(p = 0.001)和嗜碱性粒细胞相对数(p = 0.001)较高。CRC 患者的血小板计数(p < 0.001)明显较高,MPV(p = 0.003)明显较低。此外,在 CRC 患者中,MPV/PC(p < 0.001)明显较低,PLR(p < 0.001)明显较高。此外,受试者操作特征(ROC)分析表明,所有测试参数的诊断准确性都很低(AUC 为 0.7 或更低)。研究组间的 PC、MPV、MPV/PC 和 PLR 有显著差异,但 ROC 分析显示诊断准确性较差。CRC 患者的血红蛋白水平较低,这可能是由于出血次数较多、出血量较大所致。CRC 患者嗜碱性粒细胞和嗜酸性粒细胞水平较高,这表明炎症反应与 CRC 有关。
{"title":"Complete blood count parameters and inflammation-related biomarkers in patients with colorectal carcinoma.","authors":"Martha Koržinek, Ivana Ćelap, Marija Fabijanec, Tena Žanić, Neven Ljubičić, Neven Baršić, Donatella Verbanac, Karmela Barišić, Marija Grdić Rajković","doi":"10.2478/acph-2024-0036","DOIUrl":"10.2478/acph-2024-0036","url":null,"abstract":"<p><p>The aim of this study was to determine whether there are differences in complete blood count parameters (CBC) and inflammation-related biomarkers, MPV/PC, PLR, NLR, LWR, LMR, NMR, and LCR, among patients with colorectal carcinoma (CRC) and patients with colorectal adenomas. The study included 155 patients who were divided into two groups according to histopathological analysis - 74 adenomas patients and 81 CRC patients. A routine examination of CBC was conducted on Sysmex XN1000 whereas CRP was measured on Alinity ci-series. Statistical analysis was performed by ROC curve analysis using MedCalc Statistical Software. In CRC patients, hemoglobin concentration, hematocrit, MCV, MCH, and MCHC were lower, while RDW was higher (<i>p</i> < 0.001), compared to patients with adenomas. Total leukocyte count (<i>p</i> = 0 .006), absolute neutrophils (<i>p</i> = 0.005), and absolute monocytes (<i>p</i> = 0.007) were lower while relative eosinophils (<i>p</i> = 0.001) and relative basophils (<i>p</i> = 0.001) were higher in CRC patients. Platelet count (<i>p</i> < 0.001) was significantly higher and MPV (<i>p</i> = 0.003) was significantly lower in CRC patients. Furthermore, MPV/PC (<i>p</i> < 0.001) was significantly lower and PLR (<i>p</i> < 0.001) was significantly higher in CRC. Moreover, Receiver Operating Characteristic (ROC) analysis revealed poor diagnostic accuracy, for all tested parameters (AUC was 0.7 or less). PC, MPV, MPV/PC, and PLR were significantly different between study groups, but ROC analysis revealed poor diagnostic accuracy. Lower hemo globin levels in CRC patients are possibly due to more frequent and excessive bleeding. Higher levels of basophils and eosinophils in CRC patients are indicators of inflammatory reaction, which is linked to CRC.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":"739-749"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urban parks biowaste as a sustainable source of new antidiabetics. 城市公园生物废弃物作为新型抗糖尿病药物的可持续来源。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-09 Print Date: 2024-12-01 DOI: 10.2478/acph-2024-0039
Marijan Marijan, Lejsa Jakupović, Lovorka Vujić, Marina Jurić, Marijana Zovko Končić

Biowaste produced in urban parks is composed of large masses of organic matter that is only occasionally used economically. In this work, extracts of six plants widely distributed in urban parks in Central Europe (Achillea millefolium, Cichorium intybus, Malva sylvestris, Medicago sativa, Plantago lanceolata, and Trifolium pratense), prepared using 10 % and 50 % ethanol, were screened for their antidiabetic and related properties. HPLC and UV-Vis analysis revealed the presence of caffeic acid, quercetin, luteolin, and apigenin derivatives. The extracts were active in DPPH antiradical, .-carotene-linoleic acid, ORAC, and reducing power assay. They inhibited lipoxygenase, collagenase, as well as heat-induced ovalbumin coagulation. They were also able to hinder carbohydrate degradation. For example, IC 50 of anti-α-amylase activity of 10 % and 50 % ethanol extract of M. sativa extracts (204.10 ± 2.11 µg mL-1 and 78.27 ± 0.99 µg mL-1, respectively) did not statistically differ from the activity of the positive control, acarbose (284.74 ± 3.81 µg mL-1). Similar results were observed for their anti-.-glucosidase activity. In most assays, the use of 50 % ethanol was shown to be better suited for the extraction of active metabolites. The results indicate that the biowaste obtained from urban parks represents a potential source of plant material for the preparation of high-value antidiabetic products.

城市公园产生的生物垃圾是由大量的有机物质组成的,只是偶尔被经济地利用。本文以分布在中欧城市公园的六种植物(千叶阿基里斯、菊苣、木耳、苜蓿、车前草和三叶草)为原料,用10%和50%的乙醇对其抗糖尿病及相关特性进行了筛选。HPLC和UV-Vis分析显示其含有咖啡酸、槲皮素、木犀草素和芹菜素衍生物。提取物在DPPH抗自由基、-胡萝卜素-亚油酸、ORAC和还原力试验中均有活性。它们抑制脂氧合酶、胶原酶以及热诱导的卵清蛋白凝固。它们还能阻碍碳水化合物的降解。例如,10%和50%乙醇提取物的抗α-淀粉酶活性(分别为204.10±2.11µg mL-1和78.27±0.99µg mL-1)与阳性对照阿卡波糖的抗α-淀粉酶活性(284.74±3.81µg mL-1)无统计学差异。它们的抗-。葡糖苷酶的活动。在大多数分析中,使用50%乙醇被证明更适合于活性代谢物的提取。结果表明,从城市公园获得的生物废弃物是制备高价值抗糖尿病产品的潜在植物材料来源。
{"title":"Urban parks biowaste as a sustainable source of new antidiabetics.","authors":"Marijan Marijan, Lejsa Jakupović, Lovorka Vujić, Marina Jurić, Marijana Zovko Končić","doi":"10.2478/acph-2024-0039","DOIUrl":"10.2478/acph-2024-0039","url":null,"abstract":"<p><p>Biowaste produced in urban parks is composed of large masses of organic matter that is only occasionally used economically. In this work, extracts of six plants widely distributed in urban parks in Central Europe (<i>Achillea millefolium</i>, <i>Cichorium intybus</i>, <i>Malva sylvestris</i>, <i>Medicago sativa</i>, <i>Plantago lanceolata</i>, and <i>Trifolium pratense</i>), prepared using 10 % and 50 % ethanol, were screened for their antidiabetic and related properties. HPLC and UV-Vis analysis revealed the presence of caffeic acid, quercetin, luteolin, and apigenin derivatives. The extracts were active in DPPH antiradical, .-carotene-linoleic acid, ORAC, and reducing power assay. They inhibited lipoxygenase, collagenase, as well as heat-induced ovalbumin coagulation. They were also able to hinder carbohydrate degradation. For example, <i>IC</i> <sub>50</sub> of anti-<i>α</i>-amylase activity of 10 % and 50 % ethanol extract of <i>M. sativa</i> extracts (204.10 ± 2.11 µg mL-1 and 78.27 ± 0.99 µg mL-1, respectively) did not statistically differ from the activity of the positive control, acarbose (284.74 ± 3.81 µg mL<sup>-1</sup>). Similar results were observed for their anti-.-glucosidase activity. In most assays, the use of 50 % ethanol was shown to be better suited for the extraction of active metabolites. The results indicate that the biowaste obtained from urban parks represents a potential source of plant material for the preparation of high-value antidiabetic products.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 4","pages":"613-633"},"PeriodicalIF":2.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver. 酪氨酸激酶抑制剂来伐替尼被大鼠细胞色素P450氧化,并影响它们在大鼠肝脏中的表达。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-14 Print Date: 2024-09-01 DOI: 10.2478/acph-2024-0027
Radek Indra, Sandra Jelínková, Katarína Kollárová, Petra Zahumenská, Josef Dvořák, Šárka Dušková, Helena Dračínská

Lenvatinib is an orally effective tyrosine kinase inhibitor used to treat several types of tumors, including progressive, radioiodine-refractory differentiated thyroid cancer and advanced renal cell carcinoma. Although this drug is increasingly used in therapy, its metabolism and effects on the organism are still not described in detail. Using the rat as an experimental animal model, this study aimed to investigate the metabolism of lenvatinib by rat microsomal enzymes and cytochrome P450 (CYPs) enzymes recombinantly expressed in SupersomesTM in vitro and to assess the effect of lenvatinib on rat CYP expression in vivo. Two metabolites, O-desmethyl lenvatinib, and lenvatinib N-oxide, were produced by rat CYPs in vitro. CYP2A1 and 2C12 were found to be the most effective in forming O-desmethyl lenvatinib, while CYP3A2 was found to primarily form lenvatinib N-oxide. The administration of lenvatinib to rats caused changes in the expression of mRNA and protein, as well as the activity of various CYPs, particularly in an increase in CYP1A1. Thus, the administration of lenvatinib to rats has an impact on the level of CYPs.

伦伐替尼是一种口服有效的酪氨酸激酶抑制剂,用于治疗多种类型的肿瘤,包括进展期、放射性碘难治性分化型甲状腺癌和晚期肾细胞癌。虽然这种药物越来越多地被用于治疗,但其代谢和对机体的影响仍未得到详细描述。本研究以大鼠为实验动物模型,旨在研究重组在SupersomesTM中的大鼠微粒体酶和细胞色素P450(CYPs)酶对来伐替尼的体外代谢,并评估来伐替尼对大鼠体内CYP表达的影响。大鼠CYPs在体外产生了两种代谢物--O-去甲基来伐替尼和来伐替尼N-氧化物。研究发现,CYP2A1和2C12能最有效地形成O-去甲基来伐替尼,而CYP3A2则主要形成来伐替尼N-氧化物。给大鼠服用来伐替尼可导致mRNA和蛋白质的表达以及各种CYPs的活性发生变化,尤其是CYP1A1的活性增加。因此,大鼠服用来伐替尼会影响CYPs的水平。
{"title":"The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver.","authors":"Radek Indra, Sandra Jelínková, Katarína Kollárová, Petra Zahumenská, Josef Dvořák, Šárka Dušková, Helena Dračínská","doi":"10.2478/acph-2024-0027","DOIUrl":"https://doi.org/10.2478/acph-2024-0027","url":null,"abstract":"<p><p>Lenvatinib is an orally effective tyrosine kinase inhibitor used to treat several types of tumors, including progressive, radioiodine-refractory differentiated thyroid cancer and advanced renal cell carcinoma. Although this drug is increasingly used in therapy, its metabolism and effects on the organism are still not described in detail. Using the rat as an experimental animal model, this study aimed to investigate the metabolism of lenvatinib by rat microsomal enzymes and cytochrome P450 (CYPs) enzymes recombinantly expressed in Supersomes<sup>TM</sup> <i>in vitro</i> and to assess the effect of lenvatinib on rat CYP expression <i>in vivo</i>. Two metabolites, <i>O</i>-desmethyl lenvatinib, and lenvatinib <i>N</i>-oxide, were produced by rat CYPs <i>in vitro</i>. CYP2A1 and 2C12 were found to be the most effective in forming <i>O</i>-desmethyl lenvatinib, while CYP3A2 was found to primarily form lenvatinib <i>N</i>-oxide. The administration of lenvatinib to rats caused changes in the expression of mRNA and protein, as well as the activity of various CYPs, particularly in an increase in CYP1A1. Thus, the administration of lenvatinib to rats has an impact on the level of CYPs.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 3","pages":"441-459"},"PeriodicalIF":2.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tannic acid elicits differential gene regulation in prostate cancer apoptosis. 单宁酸在前列腺癌凋亡过程中引发不同的基因调控。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-14 Print Date: 2024-09-01 DOI: 10.2478/acph-2024-0020
Sinan Kandir, Sevtap Karakurt, Çiğdem Gökçek-Saraç, Serdar Karakurt

Prostate cancer is a significant global health concern that requires innovative therapeutic investigations. Here, the potential anticancer properties of tannic acid were evaluated by examining its effects on apoptosis in prostate cancer cell lines. PC-3 and LnCaP prostate adeno carcinoma cells, along with PNT1A prostate control cells, were cultured and divided into untreated and tannic acid-treated groups. Cell proliferation, cytotoxicity, and effects of tannic acid on the cell death mechanism were evaluated. mRNA expression levels of 84 genes were explored in cells following tannic acid treatment. Notably, tannic acid-induced down-regulation of several pro-survival genes, including ATM, BCL2, BCL2A1, BIK, BIRC2, BIRC3, BRE, CASP3, CASP6, CASP8, CHEK2, CRADD, PPIA, RPA3, TNFSF18, TRAF1, TRAF2, TRAF4, and TRAF5 in both cell lines. Moreover, tannic acid treatment led to the up-regulation of various pro-apoptotic genes, such as BCL10, BIRC3, BNIP3, CASP1, CASP5, CD40, CIDEB, DAPK2, FASLG, GADD45A, MYD88, RPA 3, TNFRSF10D, TNFRSF17, TNFRSF8, TNFSF13B, TNFSF4, TNFSF7, TNFSF8, TNFSF9, TP53, TRAF1, and TRAF2 in both PC-3 and LnCap cells. These findings highlight tannic acid's ability to induce apoptosis in prostate cancer cells through pro-apoptotic pathways. This study concludes that tannic acid selectively inhibits prostate cancer cell growth.

前列腺癌是全球关注的重大健康问题,需要创新的治疗研究。在此,我们通过研究单宁酸对前列腺癌细胞系凋亡的影响来评估其潜在的抗癌特性。培养 PC-3 和 LnCaP 前列腺腺癌细胞以及 PNT1A 前列腺对照细胞,并将其分为未处理组和单宁酸处理组。对单宁酸处理后细胞中 84 个基因的 mRNA 表达水平进行了研究。值得注意的是,单宁酸在两种细胞系中都诱导了一些促生存基因的下调,包括 ATM、BCL2、BCL2A1、BIK、BIRC2、BIRC3、BRE、CASP3、CASP6、CASP8、CHEK2、CRADD、PPIA、RPA3、TNFSF18、TRAF1、TRAF2、TRAF4 和 TRAF5。此外,单宁酸处理还导致了多种促凋亡基因的上调,如 BCL10、BIRC3、BNIP3、CASP1、CASP5、CD40、CIDEB、DAPK2、FASLG、GADDK2、CRADD、PPIA、RPA3、TNFSF18、TRAF1、TRAF2、TRAF4 和 TRAF5、PC-3 和 LnCap 细胞中的 FASLG、GADD45A、MYD88、RPA 3、TNFRSF10D、TNFRSF17、TNFRSF8、TNFSF13B、TNFSF4、TNFSF7、TNFSF8、TNFSF9、TP53、TRAF1 和 TRAF2。这些发现突显了单宁酸通过促凋亡途径诱导前列腺癌细胞凋亡的能力。本研究得出结论,单宁酸可选择性地抑制前列腺癌细胞的生长。
{"title":"Tannic acid elicits differential gene regulation in prostate cancer apoptosis.","authors":"Sinan Kandir, Sevtap Karakurt, Çiğdem Gökçek-Saraç, Serdar Karakurt","doi":"10.2478/acph-2024-0020","DOIUrl":"https://doi.org/10.2478/acph-2024-0020","url":null,"abstract":"<p><p>Prostate cancer is a significant global health concern that requires innovative therapeutic investigations. Here, the potential anticancer properties of tannic acid were evaluated by examining its effects on apoptosis in prostate cancer cell lines. PC-3 and LnCaP prostate adeno carcinoma cells, along with PNT1A prostate control cells, were cultured and divided into untreated and tannic acid-treated groups. Cell proliferation, cytotoxicity, and effects of tannic acid on the cell death mechanism were evaluated. mRNA expression levels of 84 genes were explored in cells following tannic acid treatment. Notably, tannic acid-induced down-regulation of several pro-survival genes, including <i>ATM, BCL2, BCL2A1, BIK, BIRC2, BIRC3, BRE, CASP3, CASP6, CASP8, CHEK2, CRADD, PPIA, RPA3, TNFSF18, TRAF1, TRAF2, TRAF4,</i> and <i>TRAF5</i> in both cell lines. Moreover, tannic acid treatment led to the up-regulation of various pro-apoptotic genes, such as <i>BCL10, BIRC3, BNIP3, CASP1, CASP5, CD40, CIDEB, DAPK2, FASLG, GADD45A, MYD88, RPA 3, TNFRSF10D, TNFRSF17, TNFRSF8, TNFSF13B, TNFSF4, TNFSF7, TNFSF8, TNFSF9, TP53, TRAF1, and TRAF2</i> in both PC-3 and LnCap cells. These findings highlight tannic acid's ability to induce apoptosis in prostate cancer cells through pro-apoptotic pathways. This study concludes that tannic acid selectively inhibits prostate cancer cell growth.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 3","pages":"539-550"},"PeriodicalIF":2.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PPIA, HRPT1, and PGK1 genes as the appropriate combination for RT-qPCR normalization in alveolar and femoral bone remodeling in olanzapine-treated rats. 将 PPIA、HRPT1 和 PGK1 基因作为奥氮平治疗大鼠牙槽骨和股骨头重塑中 RT-qPCR 正常化的适当组合。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-14 Print Date: 2024-09-01 DOI: 10.2478/acph-2024-0029
Saranda Disha-Ibrahimi, Gorazd Drevenšek, Martina Drevenšek, Janja Marc, Irena Prodan Žitnik

Reliable gene expression analysis in bone remodeling studies requires an appropriate selection of internal controls, i.e. stable reference genes for the normalization of quantitative real-time PCR (RT-qPCR), the most common method used for quantifying gene expression measurements. Even the most widely used reference genes can have variable expression under different experimental conditions, or in different tissue types or treatment regimes, so selecting appropriate controls is a key step in ensuring reliable results. The aim of this research was to identify the most stable reference gene(s) for the study of olanzapine modulated bone remodeling in rats. RNA was isolated from the maxillary alveolar and femoral bones of olanzapine or placebo-treated Wistar rats and transcribed to cDNA. The expression of 12 candidate reference genes was assessed by RT-qPCR. Their expressions were analysed using GeNorm, NormFinder, BestKeeper and delta Ct algorithms, and by the comprehensive ranking method. PPIA, HRPT1 and PGK1 were the most stably expres sed reference genes and the combination of the three genes was optimal for normalization. This study is the first to identify the optimal reference genes for research in olanzapine-exposed rats, which serve as a pivotal benchmark for enhancing the accuracy and reliability of future RT-qPCR expression in bone studies.

骨重塑研究中可靠的基因表达分析需要选择适当的内部对照,即用于定量实时 PCR(RT-qPCR)归一化的稳定参考基因,这是最常用的基因表达定量测量方法。即使是最广泛使用的参考基因,在不同的实验条件下,或在不同的组织类型或治疗方案中,其表达量也会发生变化,因此选择适当的对照是确保结果可靠的关键一步。本研究旨在为奥氮平调节大鼠骨重塑的研究确定最稳定的参考基因。从奥氮平或安慰剂治疗的 Wistar 大鼠的上颌骨牙槽骨和股骨中分离出 RNA,并转录成 cDNA。通过 RT-qPCR 评估了 12 个候选参考基因的表达。使用 GeNorm、NormFinder、BestKeeper 和 delta Ct 算法以及综合排名法分析了这些基因的表达情况。PPIA、HRPT1 和 PGK1 是表达最稳定的参考基因,这三个基因的组合是归一化的最佳选择。本研究首次为奥氮平暴露大鼠的研究确定了最佳参考基因,为今后提高骨研究中 RT-qPCR 表达的准确性和可靠性提供了重要基准。
{"title":"PPIA, HRPT1, and PGK1 genes as the appropriate combination for RT-qPCR normalization in alveolar and femoral bone remodeling in olanzapine-treated rats.","authors":"Saranda Disha-Ibrahimi, Gorazd Drevenšek, Martina Drevenšek, Janja Marc, Irena Prodan Žitnik","doi":"10.2478/acph-2024-0029","DOIUrl":"https://doi.org/10.2478/acph-2024-0029","url":null,"abstract":"<p><p>Reliable gene expression analysis in bone remodeling studies requires an appropriate selection of internal controls, <i>i.e.</i> stable reference genes for the normalization of quantitative real-time PCR (RT-qPCR), the most common method used for quantifying gene expression measurements. Even the most widely used reference genes can have variable expression under different experimental conditions, or in different tissue types or treatment regimes, so selecting appropriate controls is a key step in ensuring reliable results. The aim of this research was to identify the most stable reference gene(s) for the study of olanzapine modulated bone remodeling in rats. RNA was isolated from the maxillary alveolar and femoral bones of olanzapine or placebo-treated Wistar rats and transcribed to cDNA. The expression of 12 candidate reference genes was assessed by RT-qPCR. Their expressions were analysed using GeNorm, NormFinder, BestKeeper and delta Ct algorithms, and by the comprehensive ranking method. <i>PPIA, HRPT1</i> and <i>PGK1</i> were the most stably expres sed reference genes and the combination of the three genes was optimal for normalization. This study is the first to identify the optimal reference genes for research in olanzapine-exposed rats, which serve as a pivotal benchmark for enhancing the accuracy and reliability of future RT-qPCR expression in bone studies.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 3","pages":"511-524"},"PeriodicalIF":2.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s). 作为青霉素结合蛋白抑制剂的新型 3-氨基-4-取代单环 ß-内酰胺的合成与生化评估。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-14 Print Date: 2024-09-01 DOI: 10.2478/acph-2024-0024
Katarina Grabrijan, Nika Strašek Benedik, Alen Krajnc, Krištof Bozovičar, Damijan Knez, Matic Proj, Irena Zdovc, Izidor Sosič, Carlos Contreras-Martel, Andréa Dessen, Martina Hrast Rambaher, Stanislav Gobec

In the final phases of bacterial cell wall synthesis, penicillin-binding proteins (PBPs) catalyze the cross-linking of peptidoglycan. For many decades, effective and non-toxic β-lactam antibiotics have been successfully used as mimetics of the d-Ala-d-Ala moiety of the natural substrate and employed as irreversible inhibitors of PBPs. In the years following their discovery, the emergence of resistant bacteria led to a decline in their clinical efficacy. Using Staudinger cycloaddition, we synthesized a focused library of novel monocyclic β-lactams in which different substituents were introduced at the C4 position of the β-lactam ring, at the C3 amino position, and at the N1 lactam nitrogen. In biochemical assays, the compounds were evaluated for their inhibitory effect on the model enzyme PBP1b from Streptococcus pneumoniae. Upon investigation of the antibacterial activity of the newly prepared compounds against ESKAPE pathogens, some compounds showed moderate inhibition. We also examined their reactivity and selectivity in a biochemical assay with other enzymes that have a catalytic serine in the active site, such as human cholinesterases, where they also showed no inhibitory activity, highlighting their specificity for bacterial targets. These compounds form the basis for further work on new monocyclic β-lactams with improved antibacterial activity.

在细菌细胞壁合成的最后阶段,青霉素结合蛋白(PBPs)催化了肽聚糖的交联。几十年来,有效且无毒的 β-内酰胺类抗生素被成功地用作天然底物 d-Ala-d-Ala 分子的模拟物,并被用作 PBPs 的不可逆抑制剂。在发现这种抗生素后的几年里,耐药细菌的出现导致其临床疗效下降。我们利用施陶丁格环加成法合成了一个新型单环 β-内酰胺类化合物库,其中在 β-内酰胺环的 C4 位、C3 氨基位和 N1 内酰胺氮位引入了不同的取代基。在生化试验中,评估了这些化合物对肺炎链球菌的模型酶 PBP1b 的抑制作用。在研究新制备的化合物对 ESKAPE 病原体的抗菌活性时,一些化合物显示出中等程度的抑制作用。我们还在生化试验中检验了这些化合物与其他活性位点含有催化丝氨酸的酶类(如人类胆碱酯酶)的反应性和选择性,结果发现这些化合物也没有抑制活性,这突出表明了它们对细菌靶标的特异性。这些化合物为进一步研究具有更强抗菌活性的新型单环 β-内酰胺奠定了基础。
{"title":"Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s).","authors":"Katarina Grabrijan, Nika Strašek Benedik, Alen Krajnc, Krištof Bozovičar, Damijan Knez, Matic Proj, Irena Zdovc, Izidor Sosič, Carlos Contreras-Martel, Andréa Dessen, Martina Hrast Rambaher, Stanislav Gobec","doi":"10.2478/acph-2024-0024","DOIUrl":"https://doi.org/10.2478/acph-2024-0024","url":null,"abstract":"<p><p>In the final phases of bacterial cell wall synthesis, penicillin-binding proteins (PBPs) catalyze the cross-linking of peptidoglycan. For many decades, effective and non-toxic β-lactam antibiotics have been successfully used as mimetics of the d-Ala-d-Ala moiety of the natural substrate and employed as irreversible inhibitors of PBPs. In the years following their discovery, the emergence of resistant bacteria led to a decline in their clinical efficacy. Using Staudinger cycloaddition, we synthesized a focused library of novel monocyclic β-lactams in which different substituents were introduced at the C4 position of the β-lactam ring, at the C3 amino position, and at the N1 lactam nitrogen. In biochemical assays, the compounds were evaluated for their inhibitory effect on the model enzyme PBP1b from <i>Streptococcus pneumoniae</i>. Upon investigation of the antibacterial activity of the newly prepared compounds against ESKAPE pathogens, some compounds showed moderate inhibition. We also examined their reactivity and selectivity in a biochemical assay with other enzymes that have a catalytic serine in the active site, such as human cholinesterases, where they also showed no inhibitory activity, highlighting their specificity for bacterial targets. These compounds form the basis for further work on new monocyclic β-lactams with improved antibacterial activity.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 3","pages":"423-440"},"PeriodicalIF":2.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trifarotene alleviates skin photoaging injury by inhibition of JNK/c-Jun/MMPs. 三叶青通过抑制 JNK/c-Jun/MMPs 减轻皮肤光老化损伤。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-14 Print Date: 2024-09-01 DOI: 10.2478/acph-2024-0025
Xuan Fei, Lele Zixin Yang, Jingjing Zhang, Xiang Li, Mengtian Pan, Guangchen Xu, Cuixia Zhang, Fei Liu, Weirong Fang

Long-term exposure to ultraviolet (UV) radiation induces skin photoaging, which manifests as oxidative stress, inflammation, and collagen degradation. Multiple approaches (topical or systemic retinoids, antioxidants, alpha-hydroxy acids, laser, surgery) are used in the treatment of photoaged skin, and the use of topical retinoids is currently a primary clinical treatment. Previous studies revealed that retinoic acid promotes keratinocyte proliferation and reduces melanin deposition and matrix metalloproteinase (MMP) secretion; it also causes potential allergic and inflammatory damage to the skin. This study aimed to investigate the therapeutic effects and mechanisms of trifarotene, a functional retinoic acid analog, on UV-irradiated photoaging ICR and BALB/c nude mice and UVB photodamaged human epidermal keratinocyte (HaCaT) cells by examining indicators such as collagen, oxidoreductase, and inflammatory factor presence through histochemical staining, Western blot, and ELISA. Results suggested that trifarotene significantly reduced UV-induced photoaging in mouse skin tissue, potentially by reducing oxidative stress damage and inflammatory factor release, and inhibiting melanin deposition and collagen degradation by downregulating MMP expression. Concentrations of malondialdehyde, tyrosinase, interleukin-6, interleukin- 12, and tumor necrosis factor-alpha in photoaged skin decreased, while SOD content in photodamaged HaCaT cells significantly increased. Trifarotene (3.3 μmol L-1) inhibited phosphorylated JNK and c-Jun expression both independently and collaboratively with the JNK activator anisomycin, demonstrating that trifarotene mitigates UV-induced collagen degradation and apoptosis through inhibition of the JNK/c-Jun/MMPs signaling pathway.

长期暴露在紫外线(UV)辐射下会诱发皮肤光老化,表现为氧化应激、炎症和胶原降解。光老化皮肤的治疗采用多种方法(局部或全身维甲酸、抗氧化剂、α-羟基酸、激光、手术),其中局部维甲酸是目前临床治疗的主要方法。以往的研究表明,维甲酸能促进角质细胞增殖,减少黑色素沉积和基质金属蛋白酶(MMP)分泌,但同时也会对皮肤造成潜在的过敏和炎症损伤。本研究旨在通过组织化学染色、Western 印迹和 ELISA 等方法检测胶原蛋白、氧化还原酶和炎症因子等指标,研究功能性维甲酸类似物三萜类化合物对紫外线照射光老化的 ICR 和 BALB/c 裸鼠以及紫外线光损伤的人类表皮角质细胞(HaCaT)的治疗作用和机制。结果表明,三胡萝卜素能明显减少紫外线诱导的小鼠皮肤组织光老化,可能是通过减少氧化应激损伤和炎症因子释放,以及通过下调 MMP 表达抑制黑色素沉积和胶原降解。光老化皮肤中丙二醛、酪氨酸酶、白细胞介素-6、白细胞介素-12 和肿瘤坏死因子-α 的浓度均有所下降,而光损伤的 HaCaT 细胞中的 SOD 含量则显著增加。三叶青(3.3 μmol L-1)可单独抑制磷酸化 JNK 和 c-Jun 的表达,也可与 JNK 激活剂安乃近共同抑制磷酸化 JNK 和 c-Jun 的表达,这表明三叶青可通过抑制 JNK/c-Jun/MMPs 信号通路缓解紫外线诱导的胶原降解和细胞凋亡。
{"title":"Trifarotene alleviates skin photoaging injury by inhibition of JNK/c-Jun/MMPs.","authors":"Xuan Fei, Lele Zixin Yang, Jingjing Zhang, Xiang Li, Mengtian Pan, Guangchen Xu, Cuixia Zhang, Fei Liu, Weirong Fang","doi":"10.2478/acph-2024-0025","DOIUrl":"https://doi.org/10.2478/acph-2024-0025","url":null,"abstract":"<p><p>Long-term exposure to ultraviolet (UV) radiation induces skin photoaging, which manifests as oxidative stress, inflammation, and collagen degradation. Multiple approaches (topical or systemic retinoids, antioxidants, alpha-hydroxy acids, laser, surgery) are used in the treatment of photoaged skin, and the use of topical retinoids is currently a primary clinical treatment. Previous studies revealed that retinoic acid promotes keratinocyte proliferation and reduces melanin deposition and matrix metalloproteinase (MMP) secretion; it also causes potential allergic and inflammatory damage to the skin. This study aimed to investigate the therapeutic effects and mechanisms of trifarotene, a functional retinoic acid analog, on UV-irradiated photoaging ICR and BALB/c nude mice and UVB photodamaged human epidermal keratinocyte (HaCaT) cells by examining indicators such as collagen, oxidoreductase, and inflammatory factor presence through histochemical staining, Western blot, and ELISA. Results suggested that trifarotene significantly reduced UV-induced photoaging in mouse skin tissue, potentially by reducing oxidative stress damage and inflammatory factor release, and inhibiting melanin deposition and collagen degradation by downregulating MMP expression. Concentrations of malondialdehyde, tyrosinase, interleukin-6, interleukin- 12, and tumor necrosis factor-alpha in photoaged skin decreased, while SOD content in photodamaged HaCaT cells significantly increased. Trifarotene (3.3 μmol L-1) inhibited phosphorylated JNK and c-Jun expression both independently and collaboratively with the JNK activator anisomycin, demonstrating that trifarotene mitigates UV-induced collagen degradation and apoptosis through inhibition of the JNK/c-Jun/MMPs signaling pathway.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 3","pages":"461-478"},"PeriodicalIF":2.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability. 生物制药配方中的替代缓冲体系及其对蛋白质稳定性的影响。
IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-14 Print Date: 2024-09-01 DOI: 10.2478/acph-2024-0022
Blaž Lebar, Mitja Zidar, Janez Mravljak, Roman Šink, Aleš Žula, Stane Pajk

The formulation of biopharmaceutical drugs is designed to eliminate chemical instabilities, increase conformational and colloidal stability of proteins, and optimize interfacial stability. Among the various excipients involved, buffer composition plays a pivotal role. However, conventional buffers like histidine and phosphate buffers may not always be the optimal choice for all monoclonal antibodies (mAbs). In this study, we investigated the effects of several alternative buffer systems on seven different mAbs, exploring various combinations of ionic strengths, concentrations of the main buffer component, mAb concentrations, and stress conditions. Protein stability was assessed by analyzing soluble aggregate formation through size exclusion chromatography. At low protein concentrations, protein instability after temperature stress was exclusively observed in the bis-TRIS/ glucuronate buffer. Conversely, freeze-thaw stress led to a significant increase in aggregate formation in tested formulations, highlighting the efficacy of several alternative buffers, particularly arginine/ citrate, in preserving protein stability. Under temperature stress, the introduction of arginine to histidine buffer systems provided additional stabilization, while the addition of lysine resulted in protein destabilization. Similarly, the incorporation of arginine into histi-dine/HCl buffer further enhanced protein stability during freeze--thaw cycles. At high protein concentrations, the histidine/citrate buffer emerged as one of the most optimal choices for addressing temperature and light-induced stress. The efficacy of histidine buffers in combating light stress might be attributed to the light-absorbing properties of histidine molecules. Our findings demonstrate that the development of biopharmaceutical formulations should not be confined to conventional buffer systems, as numerous alternative options exhibit comparable or even superior performance.

生物制药的配方设计旨在消除化学不稳定性,提高蛋白质的构象和胶体稳定性,以及优化界面稳定性。在所涉及的各种辅料中,缓冲成分起着举足轻重的作用。然而,组氨酸缓冲液和磷酸盐缓冲液等传统缓冲液并不总是所有单克隆抗体(mAbs)的最佳选择。在这项研究中,我们研究了几种可供选择的缓冲体系对七种不同 mAbs 的影响,探索了离子强度、主要缓冲成分浓度、mAb 浓度和应力条件的各种组合。通过尺寸排阻色谱分析可溶性聚集体的形成,评估了蛋白质的稳定性。在蛋白质浓度较低的情况下,只有在双-TRIS/葡萄糖醛酸缓冲液中才能观察到温度应激后蛋白质的不稳定性。相反,冻融应力会导致测试配方中聚集体的形成显著增加,这凸显了几种替代缓冲液(尤其是精氨酸/柠檬酸盐缓冲液)在保持蛋白质稳定性方面的功效。在温度应力下,组氨酸缓冲体系中加入精氨酸可提供额外的稳定性,而加入赖氨酸则会导致蛋白质不稳定。同样,在组氨酸/盐酸盐缓冲液中加入精氨酸可进一步提高蛋白质在冻融循环中的稳定性。在蛋白质浓度较高的情况下,组氨酸/柠檬酸盐缓冲液成为应对温度和光诱导胁迫的最佳选择之一。组氨酸缓冲液对抗光胁迫的功效可能归因于组氨酸分子的光吸收特性。我们的研究结果表明,生物制药配方的开发不应局限于传统的缓冲体系,因为许多替代选择都具有类似甚至更优越的性能。
{"title":"Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability.","authors":"Blaž Lebar, Mitja Zidar, Janez Mravljak, Roman Šink, Aleš Žula, Stane Pajk","doi":"10.2478/acph-2024-0022","DOIUrl":"https://doi.org/10.2478/acph-2024-0022","url":null,"abstract":"<p><p>The formulation of biopharmaceutical drugs is designed to eliminate chemical instabilities, increase conformational and colloidal stability of proteins, and optimize interfacial stability. Among the various excipients involved, buffer composition plays a pivotal role. However, conventional buffers like histidine and phosphate buffers may not always be the optimal choice for all monoclonal antibodies (mAbs). In this study, we investigated the effects of several alternative buffer systems on seven different mAbs, exploring various combinations of ionic strengths, concentrations of the main buffer component, mAb concentrations, and stress conditions. Protein stability was assessed by analyzing soluble aggregate formation through size exclusion chromatography. At low protein concentrations, protein instability after temperature stress was exclusively observed in the bis-TRIS/ glucuronate buffer. Conversely, freeze-thaw stress led to a significant increase in aggregate formation in tested formulations, highlighting the efficacy of several alternative buffers, particularly arginine/ citrate, in preserving protein stability. Under temperature stress, the introduction of arginine to histidine buffer systems provided additional stabilization, while the addition of lysine resulted in protein destabilization. Similarly, the incorporation of arginine into histi-dine/HCl buffer further enhanced protein stability during freeze--thaw cycles. At high protein concentrations, the histidine/citrate buffer emerged as one of the most optimal choices for addressing temperature and light-induced stress. The efficacy of histidine buffers in combating light stress might be attributed to the light-absorbing properties of histidine molecules. Our findings demonstrate that the development of biopharmaceutical formulations should not be confined to conventional buffer systems, as numerous alternative options exhibit comparable or even superior performance.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":"74 3","pages":"479-493"},"PeriodicalIF":2.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142278650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Pharmaceutica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1